AIM
ABBV icon

Advyzon Investment Management’s AbbVie ABBV Stock Holding History

Advyzon Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Buy
15,694
+2,688
+21% +$578K 0.29% 83
2026
Q1 		$2.83M Buy
13,006
+1,784
+16% +$396K 0.25% 92
2025
Q4 		$579K Buy
11,222
+5,542
+98% +$1.26M 0.07% 285
2025
Q3 		$1.32M Buy
5,680
+1,547
+37% +$315K 0.23% 102
2025
Q2 		$767K Buy
4,133
+925
+29% +$172K 0.17% 122
2025
Q1 		$672K Sell
3,208
-815
-20% -$158K 0.24% 82
2024
Q4 		$715K Buy
+4,023
New +$740K 0.28% 75

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advyzon Investment Management's ABBV Position: Q2 2026 in Review

Advyzon Investment Management increased its AbbVie (ABBV) stake by 21% in Q2 2026, buying an estimated $578K and bringing the position to 15,694 shares worth $3.95M. The position accounts for 0.29% of the portfolio, ranked #83.

Advyzon Investment Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Advyzon Investment Management held 15,694 shares of AbbVie worth $3.95M as of Q2 2026.
  • Advyzon Investment Management bought 2,688 AbbVie shares in Q2 2026, an estimated $578K.
  • AbbVie made up 0.29% of Advyzon Investment Management's portfolio in Q2 2026, its #83 holding.
  • Advyzon Investment Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.